Beddow Capital Management Inc. Buys 307 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Beddow Capital Management Inc. boosted its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 37.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,125 shares of the medical instruments supplier’s stock after purchasing an additional 307 shares during the quarter. Beddow Capital Management Inc.’s holdings in Mettler-Toledo International were worth $1,377,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in MTD. Proficio Capital Partners LLC bought a new stake in Mettler-Toledo International in the fourth quarter valued at about $163,216,000. Seilern Investment Management Ltd acquired a new position in Mettler-Toledo International in the fourth quarter valued at about $89,221,000. AustralianSuper Pty Ltd grew its stake in Mettler-Toledo International by 3,183.2% in the fourth quarter. AustralianSuper Pty Ltd now owns 71,673 shares of the medical instruments supplier’s stock valued at $87,705,000 after acquiring an additional 69,490 shares during the period. Canoe Financial LP grew its stake in Mettler-Toledo International by 576.5% in the fourth quarter. Canoe Financial LP now owns 55,518 shares of the medical instruments supplier’s stock valued at $67,936,000 after acquiring an additional 47,311 shares during the period. Finally, Wealthfront Advisers LLC grew its stake in Mettler-Toledo International by 4,357.4% in the fourth quarter. Wealthfront Advisers LLC now owns 35,258 shares of the medical instruments supplier’s stock valued at $43,145,000 after acquiring an additional 34,467 shares during the period. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,198.09 on Friday. The stock has a 50 day moving average price of $1,292.72 and a 200 day moving average price of $1,310.84. Mettler-Toledo International Inc. has a 52 week low of $1,142.91 and a 52 week high of $1,546.93. The stock has a market capitalization of $24.97 billion, a PE ratio of 29.56, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, research analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other news, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at $8,108.04. This trade represents a 99.01 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Christian Magloth sold 790 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on MTD. Evercore ISI boosted their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. Robert W. Baird boosted their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Wells Fargo & Company upped their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, February 10th. Finally, Citigroup reduced their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $1,380.50.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.